BIAFINE

This brand name is authorized in Ecuador, France, Israel, Malta, Tunisia

Active ingredients

The drug BIAFINE contains one active pharmaceutical ingredient (API):

1 Trolamine
UNII 9O3K93S3TK - TROLAMINE
Read about Trolamine

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
BIAFINE Emulsion for cutaneous application Medicines Authority (MT) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
D03AX12 D Dermatologicals → D03 Preparations for treatment of wounds and ulcers → D03A Cicatrizants → D03AX Other cicatrizants
Discover more medicines within D03AX12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 582-MEE-0115
Country: FR Base de données publique des médicaments Identifier(s): 69931588
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 3003, 3004
Country: MT Medicines Authority Identifier(s): MA065/00101
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 11283011, 11283012

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.